Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 9/20 | 0.33 |
| ▸ | DRD2 | P14416 | 7/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22347570 | 0.79 | DRD3 (0.36) | KMT2AMAPTDRD3DRD2 | |
| SCHEMBL22347741 | 0.73 | KMT2A (0.36) | KMT2AFAAHTRPV1CYP1A2GAA | |
| SCHEMBL22354343 | 0.72 | NR1H4 (0.39) | NR1H4 | |
| SCHEMBL22347486 | 0.70 | DRD2 (0.30) | DRD3DRD2 | |
| SCHEMBL22347370 | 0.70 | DRD2 (0.32) | DRD3DRD2NR1H4 | |
| SCHEMBL22347284 | 0.70 | NR1H4 (0.39) | KMT2ANR1H4 | |
| SCHEMBL22347408 | 0.69 | DRD3 (0.35) | DRD3DRD2 | |
| SCHEMBL6228259 | 0.65 | KMT2A (0.59) | KMT2ACYP1A2GAAMAPTRECQL | |
| SCHEMBL22347333 | 0.63 | DRD2 (0.31) | DRD3DRD2 | |
| SCHEMBL28052009 | 0.63 | L3MBTL1 (0.59) | KMT2ACYP1A2GAAMAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924336-A1 | SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | Bristol-Myers Squibb Company (US) | 2021-12-22 | — | — | EP | disclosed |
| WO-2020168143-A1 | SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-08-20 | — | — | WO | disclosed |